Elanco Animal Health Incorporated updated earnings guidance for the full year 2021 and provided earnings guidance for the second quarter of 2021. Updating financial guidance for the full year 2021 with revenue of $4,680 million to $4,730 million, diluted LPS of $0.35 to $0.26 on a reported basis, or $1.00 to $1.06 on an adjusted basis, reported net loss of $170 million to $125 million. Providing financial guidance for the second quarter of 2021 with revenue of $1,225 to $1,255 million, diluted LPS of $0.08 to $0.01 on a reported basis, or $0.22 to $0.27 on an adjusted basis, reported net loss of $35 million to $10 million.